EIPR1

Across TCGA pan-cancer cohorts, EIPR1 RNA differs between tumor and matched normal tissue in 16 of 18 cancer types tested, making tumor–normal expression one of EIPR1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where EIPR1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EIPR1 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

COAD, BLCA, and LUAD are the cancer types where EIPR1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EIPR1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	III,IV	+1.293	<.001	11	view →
BLCA	Male	III,IV	+1.162	<.001	11	view →
LUAD	Male	II,III,IV	+0.911	<.001	11	view →
THCA	Male	III,IV	−1.188	<.001	10	view →
LUSC	Female	II,III,IV	+1.241	<.001	9	view →
STAD	Male	III,IV	+1.076	<.001	9	view →
LIHC	Female	II,III,IV	+1.000	<.001	9	view →
KICH	Female	II,III,IV	−1.230	<.001	8	view →
HNSC	Male	All	+0.562	<.001	8	view →
UCEC	All	III,IV	+0.978	<.001	6	view →
BRCA	All	III,IV	+0.801	<.001	6	view →
CHOL	Female	All	+2.393	<.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 16 lineages.

EIPR1–COAD

Open the COAD breakdown →